Olivia Willis
speaker
783 appearances
14 recordings
2 series
first heard Oct 2017
last heard May 2021
Olivia Willis’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Um and I guess that really aligns with what we already know, which is
The longer women use HRT, the higher the risk they are in terms of breast cancer.
But I should say that you know it's important to weigh up these risk factors in the context of other breast cancer risk factors.
So we know things like age, weight, alcohol intake, family history, those are all really important.
And we also need to think about this in the context of the need for treatment and symptom symptom relief.
So we know you know a lot of women start using hormone treatment.
treatments around the time of menopause to manage symptoms like hot flushes, night sweats, vaginal dryness, all of which can have a really, you know, significant impact on quality of life.
And so that also needs to be taken into account.
Yeah, so in Western countries the incidence of breast cancer among women who have never used HRT is about six point three per 100 women.
Uh so that means you know you've got a kind of six point three percent chance of developing the disease anyway if you haven't used the treatment.
So for those using HRT for five years, which is about the average, their breast cancer risk increases by about 2% if they're using the estrogen plus daily progestrogen uh therapy.
If they're using estrogen plus intermittent progestrogen, so that's about 10 to 14 days half of the month, uh it's about a 1.4% increase.
And then for women using the estrogen-only therapy, it's very small, so it's about a 0.5% increase.
Yeah, look, I think the research is certainly the findings I don't think they're not suggesting that women should immediately stop using HRT.
It's still very much a viable option, um, certainly in the short term and potentially medium term, you know, for the management of of menopause symptoms.
I think probably the message here and from researchers is that that treatments n longer than one year, you know, need to be carefully considered.
Um, and that, you know, you
need to take into account individual risk factors, the ones that we've mentioned, age, weight, alcohol intake, family history, so on, and also the need for symptom relief that I spoke about.
So I think, you know, with most things like this, it's about a conversation that women will have with their GP and very much personal factors.
Pleasure.
Showing 421–440 of 783 · page 22 of 40
← Previous
Next →